Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea

Unilateral transvenous PNS with Remedē System in patients with CSA is associated with a high response to therapy through 36 months follow-up as well as echocardiography parameters through 24 months. The benefits appear to be sustained with no safety concerns.

3. Long term efficacy and safety of phrenic nerve stimulation for the treatment od CSA

.pdf

Download PDF • 3.94MB